Related Experiment Videos
New drugs on the horizon
G M el-Chaar1, M H Schwenk, J Bardini
1Saint John's University College of Pharmacy and Allied Health Professions, Jamaica, New York.
Clinics in Podiatric Medicine and Surgery
|April 1, 1992
Summary
Biotechnology, including recombinant DNA and monoclonal antibodies, drives the creation of novel protein drugs for diverse diseases. Future efforts aim to develop unique therapeutics offering significant therapeutic advancements.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Drug Discovery and Development
Background:
- Biotechnology is a key driver in modern drug development.
- Advances enable production of previously unavailable protein therapeutics.
Purpose of the Study:
- To review the role of biotechnology in drug development.
- To highlight the potential for novel therapeutic agents.
Main Methods:
- Review of biotechnology techniques, including recombinant DNA and monoclonal antibodies.
- Analysis of their application in producing protein drugs.
Main Results:
- Biotechnology facilitates the creation of pure and abundant protein drugs.
- These agents address a wide spectrum of diseases, including infections, cancers, and cardiovascular/gastrointestinal conditions.
Conclusions:
- Biotechnology is crucial for developing advanced therapeutics.
- Continued focus on unique drug development promises significant therapeutic gains.